Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neurotech International Ltd. (AU:NTI)
ASX:NTI
RESEARCH TOOLSreports
Holding AU:NTI?
Track your performance easily
NTI Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.13
Previous CloseAU$0.07
Volume1.18M
Average Volume (3M)731.24K
Market Cap
AU$76.80M
Enterprise ValueAU$69.49M
Total Cash (Recent Filing)AU$1.90M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Mar 04, 2025EPS Estimate
>-AU$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume629,042
30 Day Avg. Volume731,241
Standard Deviation0.31
R-Squared0.11
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)928.85
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neurotech International Ltd. News
PremiumCompany Announcements
Neurotech Secures FDA Orphan Drug Status Boost
PremiumCompany Announcements
Neurotech International Advances NTI164 Drug Trials
PremiumCompany Announcements
Neurotech International’s AGM Success and Trial Progress
PremiumCompany Announcements
Neurotech International Advances NTI164 and Strengthens Leadership
PremiumCompany Announcements
Neurotech Announces Positive Trial Results for NTI164
PremiumCompany Announcements
Neurotech’s NTI164 Shows Promise in Neurological Treatment
PremiumCompany Announcements
Neurotech International to Issue 20 Million OptionsPremiumCompany Announcements
Neurotech International Appoints New CEO to Drive GrowthOptions Prices
Currently, No data available
---
Ownership Overview
NTI FAQ
What was Neurotech International Ltd.’s price range in the past 12 months?
Neurotech International Ltd. lowest share price was AU$0.05 and its highest was AU$0.13 in the past 12 months.
What is Neurotech International Ltd.’s market cap?
Currently, no data Available
When is Neurotech International Ltd.’s upcoming earnings report date?
Neurotech International Ltd.’s upcoming earnings report date is Mar 04, 2025 which is in 97 days.
How were Neurotech International Ltd.’s earnings last quarter?
Neurotech International Ltd. released its earnings results on Aug 28, 2024. The company reported -AU$0.004 earnings per share for the quarter, the consensus estimate of -AU$0.004 by AU$0.
Is Neurotech International Ltd. overvalued?
According to Wall Street analysts Neurotech International Ltd.’s price is currently Overvalued.
Does Neurotech International Ltd. pay dividends?
Neurotech International Ltd. does not currently pay dividends.
What is Neurotech International Ltd.’s EPS estimate?
Neurotech International Ltd.’s EPS estimate is >-AU$0.01.
How many shares outstanding does Neurotech International Ltd. have?
Neurotech International Ltd. has 1,034,622,000 shares outstanding.
What happened to Neurotech International Ltd.’s price movement after its last earnings report?
Neurotech International Ltd. reported an EPS of -AU$0.004 in its last earnings report, expectations of -AU$0.004. Following the earnings report the stock price went up 14.286%.
Which hedge fund is a major shareholder of Neurotech International Ltd.?
Currently, no hedge funds are holding shares in AU:NTI
---
Neurotech International Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NTI Sentiment 78%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
21.05%
12-Months-Change
Fundamentals
Return on Equity
-63.92%
Trailing 12-Months
Asset Growth
130.06%
Trailing 12-Months
Company Description
Neurotech International Ltd.
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activity of the firm is functioned through the region of Australia.
---
Technical Analysis
---